Publicacións nas que colabora con Yolanda Pazos Randulfe (8)

2018

  1. Erratum to: Obestatin controls skeletal muscle fiber-type determination (Scientific Reports, (2017), 7, 1, (2137), 10.1038/s41598-017-02337-4)

    Scientific Reports

  2. Improvement of Duchenne muscular dystrophy phenotype following obestatin treatment

    Journal of Cachexia, Sarcopenia and Muscle, Vol. 9, Núm. 6, pp. 1063-1078

2017

  1. Obestatin controls skeletal muscle fiber-type determination

    Scientific Reports, Vol. 7, Núm. 1

2016

  1. Distinct phosphorylation sites on the ghrelin receptor, GHSR1a, establish a code that determines the functions of ß-arrestins

    Scientific Reports, Vol. 6

2015

  1. Action of obestatin in skeletal muscle repair: Stem cell expansion, muscle growth, and microenvironment remodeling

    Molecular Therapy, Vol. 23, Núm. 6, pp. 1003-1021

2012

  1. The obestatin/GPR39 system is up-regulated by muscle injury and functions as an autocrine regenerative system

    Journal of Biological Chemistry, Vol. 287, Núm. 45, pp. 38379-38389

2011

  1. Preproghrelin expression is a key target for insulin action on adipogenesis

    Journal of Endocrinology, Vol. 210, Núm. 2

  2. The SHP-1 protein tyrosine phosphatase negatively modulates Akt signaling in the ghrelin/GHSR1a system

    Molecular Biology of the Cell, Vol. 22, Núm. 21, pp. 4182-4191